Articles On Sigma Healthcare (ASX:SIG)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Australian shares: A once-in-a-decade chance to build wealth?
At first glance, the Australian share market doesn't look particularly cheap. Even after the recent pullback driven by escalating tensions in the Middle East, the S&P/ASX 200 Index (ASX: XJO) is still sitting not far from record hig... |
Motley Fool | SIG | 1 day ago |
|
2 strong Australian stocks to buy now with $6,000
I'm excited about the potential behind Australian stocks looking to go global with their growth. Australia is a great country to do business in, but with less than 30 million people in Australia it's important to recognise there are othe... |
Motley Fool | SIG | 1 day ago |
|
Scott Power: ASX healthcare sector reels after another tough week
ASX health sector falls about 2.5% for the past five days while broader market is just scraping by as the Middle East conflict takes a toll Immutep plunges 90% on Friday after abandoning its Phase III trial of lung cancer treatment Pro Me... |
Stockhead | SIG | 5 days ago |
|
5 incredible ASX 200 shares I'd buy with $10,000
Many investors eventually reach a point where they have some spare cash ready to put into the share market. Whether that money is being used to start a new position, add to an existing holding, or simply take advantage of opportunities... |
Motley Fool | SIG | 5 days ago |
|
3 of the best ASX 200 shares to buy and hold forever
Some companies are built to benefit from short-term trends. Others are built to endure. When I think about ASX 200 shares I could happily hold for decades, I usually look for businesses with strong competitive positions, long growth runw... |
Motley Fool | SIG | 6 days ago |
|
3 ASX 200 shares at 52-week lows I'd buy before they recover
Seeing a company hit a 52-week low can make investors nervous. But in many cases, those moments can create opportunities rather than warnings. Here are three ASX 200 shares currently trading near their lows that I think could be worth co... |
Motley Fool | SIG | 1 week ago |
|
Scott Power: Healthcare struggles as markets turn risk-off
ASX health sector flat for the week, while the S&P/ASX 200 falls xx% as Middle East conflict takes a toll on global markets LTR Pharma completes recruitment for a phase II pharmacokinetic clinical study of erectile dysfunction treatmen... |
Stockhead | SIG | 1 week ago |
|
5 Australian stocks to buy and hold for the next 5 years
Investing for the next five years doesn't require predicting every twist in the market. What matters more, in my view, is owning businesses with durable advantages, solid growth prospects, and management teams that know how to allocate c... |
Motley Fool | SIG | 1 week ago |
|
The Overnight Report: Securing The Strait
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets recovered off intraday lows on confirmation the US Administration is taki... |
FNArena | SIG | 2 weeks ago |
|
5 things to watch on the ASX 200 on Wednesday
On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was out of form and tumbled lower. The benchmark index fell 1.35% to 9,077.3 points. Will the market be able to bounce back from this on Wednesday? Here are five things to watch: ASX 200 to... |
Motley Fool | SIG | 2 weeks ago |
|
3 ASX 200 shares at 52-week lows: Buy, hold, or sell?
S&P/ASX 200 Index (ASX: XJO) shares closed 1.34% lower at 9,077.3 points yesterday, after matching Monday's record high of 9,200.9 points during intraday trading. The market took a breather yesterday to assess the impact of the US a... |
Motley Fool | SIG | 2 weeks ago |
|
The Overnight Report: Big Rebound Off Lows
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets recounded off intraday lows with technology stocks finding buying support... |
FNArena | SIG | 2 weeks ago |
|
Buy, hold, sell: HMC Capital, Ramsay Health Care, and Sigma shares
The team at Morgans has been busy reviewing the countless results released last month. Let's see what the broker is saying about the popular ASX shares listed below and whether it thinks there's a buying opportunity here for investors. Here... |
Motley Fool | SIG | 2 weeks ago |
|
2 great ASX 200 blue-chip shares I'd buy right now
S&P/ASX 200 Index (ASX: XJO) blue-chip shares can deliver strong and resilient earnings thanks to their market position, margins, and brand power. I'm not particularly attracted to ASX mining or bank shares, but there are other ind... |
Motley Fool | SIG | 2 weeks ago |
|
The Monday Report – 02 March 2026
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets were weaker on Friday, but all eyes are now focused on Iran and the Middl... |
FNArena | SIG | 2 weeks ago |
|
FNArena Corporate Results Monitor – 27-02-2026
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke... |
FNArena | SIG | 2 weeks ago |
|
Scott Power: Another ‘bloody week’ for healthcare, but Ramsay swings hard on turnaround
The local healthcare sector fell 1.6% this week as reporting season continued Sigma delivered “solid” first-half results underscoring its merger with Chemist Warehouse Ramsay soared after its H1 FY26 profit beat forecasts with NPAT of $17... |
Stockhead | SIG | 2 weeks ago |
|
Is it too late to buy the shares of Chemist Warehouse owner Sigma?
Sigma Healthcare Ltd (ASX: SIG) shares were bouncing around on Thursday. The Chemist Warehouse owner's shares were up as high as $3.20, just short of a 52-week high, before closing down at $2.94. Should you be taking advantage of the pullba... |
Motley Fool | SIG | 2 weeks ago |
|
Biocurious: Healthcare leaders given the cold shoulder in a lovelorn reporting season
February may have included Valentine’s Day, but investors didn’t show a great deal of love for our revenue-generating healthcare stocks Companies producing ambivalent results were whacked while the poor performers were hit even harder But... |
Stockhead | SIG | 2 weeks ago |
|
Weight-loss drugs a shot in the arm for Chemist Warehouse and Sigma Healthcare
Discount pharmacy juggernaut Chemist Warehouse has attributed its double-digit sales lift to the growing popularity of weight-loss drugs like Ozempic and Mounjaro. |
The West | SIG | 2 weeks ago |
|
Closing Bell: Back-to-back records put ASX on best run since May
Back-to-back record closes for S&P/ASX 200 Index on track for strongest month in nine months Nvidia fireworks and miner muscle drive gains The S&P/ASX 200 notched a second straight record close on Thursday, rising 0.51% to 9175... |
Stockhead | SIG | 2 weeks ago |
|
Market momentum lifts sentiment as leading ASX names reshape outlook
Highlights Technology strength steadies market tone Healthcare activity improves sentiment Industrial pressure reshapes outlook Sector rotation shaped Australian equities as technology and healthcare strength offset in... |
Kalkine Media | SIG | 2 weeks ago |
|
Why Accent Group, DroneShield, IDP Education, and Sigma shares are jumping today
The S&P/ASX 200 Index (ASX: XJO) is on form again on Thursday and charging higher. In afternoon trade, the benchmark index is up 0.6% to 9,182.2 points. Four ASX shares that are rising more than most today are listed below. Here's why... |
Motley Fool | SIG | 2 weeks ago |
|
Health Check: Anti-obesity drugs fatten Chemist Warehouse profits
Sigma Health expects ongoing benefit from GLP-1 prescriptions, rather than a peripheral “RAT test” effect Alcidion posts record first half revenues Nova eyes earnings breakeven in the second half Anti-obesity drug prescriptions have pla... |
Stockhead | SIG | 2 weeks ago |
|
Sigma shares jump 7% on results and Chemist Warehouse expansion
Sigma Healthcare Ltd (ASX: SIG) shares are having a strong start to the day. In morning trade, the Chemist Warehouse owner's shares are up 7% to $3.20. This follows the release of another strong half-year result from the retail pharmacy fra... |
Motley Fool | SIG | 2 weeks ago |
|
DroneShield wins $21.7m in western military contracts
The DroneShield Ltd (ASX: DRO) share price is in focus after announcing a package of six contracts totalling $21.7 million with a western military end-customer. The contracts cover dismounted counter-drone systems, spares, and software, wit... |
Motley Fool | SIG | 2 weeks ago |
|
Atlas Arteria results: 2025 toll revenue climbs, 40c distribution on track
The Atlas Arteria Group (ASX: ALX) share price is in focus today after the company unveiled its 2025 fullâyear results, which saw a 9.4% lift in proportional toll revenue and a reaffirmed distribution guidance. What did Atlas Arteria repo... |
Motley Fool | SIG | 2 weeks ago |
|
Sigma Healthcare shares: 1H26 profit and sales leap
The Sigma Healthcare Ltd (ASX: SIG) share price is in focus today after the company reported 1H26 revenue of $5.5 billion (up 14.9%) and normalised NPAT of $392 million (up 19.2%). What did Sigma Healthcare report? Revenue increased 14.9%... |
Motley Fool | SIG | 2 weeks ago |
|
Qantas earnings: Profit up, higher dividends, and bigger fleet for FY26
The Qantas Airways Ltd (ASX: QAN) share price is in focus today as the company reported a $1,456 million underlying profit before tax for the first half of FY26, with revenue rising to $12.9 billion. The airline also boosted its fully frank... |
Motley Fool | SIG | 2 weeks ago |
|
Westgold Resources posts record profit and revenue for H1 FY26
The Westgold Resources Ltd (ASX: WGX) share price is in focus today after the ASX 200 gold miner reported a record half-year profit of $190.7 million and nearly doubled its revenue to $1.24 billion for the six months ended 31 December 2025.... |
Motley Fool | SIG | 2 weeks ago |
|
Vault Minerals posts half-year earnings; declares maiden dividend
The Vault Minerals Ltd (ASX: VAU) share price is in focus today after the company unveiled a strong set of half-year results, highlighted by a robust 44% lift in group EBITDA to $384.5 million and the declaration of a maiden 7 cents per sha... |
Motley Fool | SIG | 2 weeks ago |
|
The Overnight Report: Nvidia Saves The Day?
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US technology stocks continued to lead US markets higher overnight. Post close Sales... |
FNArena | SIG | 2 weeks ago |
|
Market Open: Aussie earnings roll on toward Feb finish line; US tech rally keeps WK9 very green | Feb 26
ASX today – We’re heading into Thursday morning on the upswing in Australia, mainly thanks to Wall Street continuing its advance. Next, things turn to the biggest reporting day of the February earnings season Down Under. Listen to the Ho... |
themarketonline.com.au | SIG | 2 weeks ago |
|
Corporate Travel Management posts $348.5m 1H26 revenue and UK remediation update
Today, Corporate Travel Management Ltd (ASX: CTD) reported unaudited first-half (1H26) revenue of $348.5 million and underlying EBITDA of $77.7 million, alongside further progress on its UK remediation plan. What did Corporate Travel Manage... |
Motley Fool | SIG | 2 weeks ago |
|
Air New Zealand reports half-year loss
The Air New Zealand Ltd (ASX: AIZ) share price is in focus today as the company posted a half-year loss of $40 million after tax and announced no interim dividend, impacted by engine maintenance delays and rising costs. What did Air New Zea... |
Motley Fool | SIG | 2 weeks ago |
|
5 ASX 200 blue chip stocks I would buy with $50,000
If I had $50,000 to deploy into ASX 200 blue chips today, I would try and focus on quality. This means market leaders and businesses with competitive advantages and the ability to grow earnings over time. They may not necessarily b... |
Motley Fool | SIG | 2 weeks ago |
|
Are Tabcorp shares a buy after soaring 24% following its half-year result?
Tabcorp Holdings Ltd (ASX: TAH) shares surged an enormous 23.53% on Wednesday. At the close of the ASX the shares had jumped to $1.05 a piece. It was the best-performing stock on the S&P/ASX 200 Index (ASX: XJO) for the day. The s... |
Motley Fool | SIG | 2 weeks ago |
|
Why I'd forget NAB shares and buy these top Aussie stocks
National Australia Bank Ltd (ASX: NAB) shares hit a record high yesterday. That kind of price action tells you one thing very clearly: the market is feeling confident. And while I can understand why investors are drawn to banks, especial... |
Motley Fool | SIG | 3 weeks ago |
|
3 of the best Aussie stocks I would buy
When I look for the best Aussie stocks to buy, I'm looking for businesses with strong management teams, robust business models, and clear growth drivers that can play out over many years. Right now, three Aussie stocks stand out to me fo... |
Motley Fool | SIG | 3 weeks ago |
|
Scott Power: ‘Little rays of sunshine’ in stormy ASX healthcare reporting season
The ASX healthcare sector fell 0.73% this week as reporting season continued Pathology and radiology provider Sonic Healthcare rises with H1 results ahead of expectations Morgans lifts its target price for protective gear maker Ansell afte... |
Stockhead | SIG | 3 weeks ago |
|
5 top ASX 200 shares I would buy with $5,000
If I had $5,000 ready to invest in the ASX 200 right now, I wouldn't overcomplicate it. I'd spread it across a handful of businesses that I believe have genuine growth potential and strong long-term positioning. Here are five ASX 200 sha... |
Motley Fool | SIG | 1 month ago |
|
The $10,000 Test: Which ASX shares would I still own after 10 years?
Every now and then, I like to run a simple thought experiment. If I invested $10,000 today and was not allowed to sell, check, or tweak the portfolio for the next decade, which ASX shares would I feel comfortable locking away? It is a... |
Motley Fool | SIG | 1 month ago |
|
Rudi Interviewed: February Is Less About Earnings
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck Transcript of Pre-February results interview by Livewire Markets. By... |
FNArena | SIG | 1 month ago |
|
ASX 200 Market Activity: What Today’s Most Traded Stocks Reveal
Highlights Heavy trading reflected shifting market positioning Resources and technology names stayed in focus Activity patterns offered clues across key ASX segments Recent ASX activity highlights shifting attention ac... |
Kalkine Media | SIG | 1 month ago |
|
Why ASX 200 Market Movers Are Drawing Fresh Attention
highlights Market activity spotlighted across major Australian shares Liquidity trends reveal shifting sentiment in large capitalisation names Sector diversity shapes broader ASX dynamics Market activity across Austral... |
Kalkine Media | SIG | 1 month ago |
|
Health Check: With a heady valuation, ‘quiet’ Sigma faces its day of earnings reckoning
Chemist Warehouse’s owner needs to show it has the growth prescription at its upcoming results Memphasys shares soar up to 25% on TGA approval Truscreen’s developing world rollout continues apace Sigma Healthcare (ASX:SIG) has proved t... |
Stockhead | SIG | 1 month ago |
|
Instead of Westpac shares, I would buy these ASX blue chips
Westpac Banking Corp (ASX: WBC) shares have had a solid run, and for many investors it has done exactly what a big bank is supposed to do. It has paid dividends, offered stability, and benefited from a strong banking cycle. But looking ahea... |
Motley Fool | SIG | 1 month ago |
|
Can South32 shares keep surfing the commodities boom?
South32 Ltd (ASX: S32) shares have rushed to 52-week highs in the past month. In the past 6 months, the share price has soared by 58% to $4.62 at the time of writing. In 2025, South32 shares experienced a rough patch that saw the mining... |
Motley Fool | SIG | 1 month ago |
|
Scott Power: Quarterly results build momentum for ASX healthcare stocks
ASX health sector up 0.11% for the week, while broader market rises 0.23% Week dominated by quarterly results with several companies reaching key milestones Morgans upgrades Imricor after US FDA breakthrough clearance for its NorthStar M... |
Stockhead | SIG | 1 month ago |
|
2 Australian stocks I would buy in 2026
When it comes to finding Australian stocks to buy, I'm more interested in long-term compounding than short-term trades. Two stocks that I think fit the bill for long-term investments are discussed in this article. Here's why I'd feel com... |
Motley Fool | SIG | 1 month ago |